The 2013 WHO classification classified SRCs as the ICL type with targetoid appearance and the non-ICL type with abundant intracytoplasmic mucin as observed in gastric carcinoma; however, the clinical significance of SRC types remains uncertain [14]. This evidence concerns the gene MUC5AC and gastric carcinoma.